View Older Stories View More Recent Stories

Jun 24, 2024 08:46AM Anixa Biosciences (ANIX) Treats Sixth Patient in its Ovarian Cancer CAR-T Trial
Jun 24, 2024 08:45AM Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
May 21, 2024 07:30AM Anixa Biosciences (ANIX) Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
May 21, 2024 07:30AM Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
May 8, 2024 08:25AM Anixa Biosciences (ANIX) Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
May 8, 2024 08:25AM Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
May 6, 2024 08:05AM Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
Apr 30, 2024 07:45AM Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
Apr 18, 2024 08:21AM Anixa Biosciences (ANIX) Appoints Sanjay Juneja to its Cancer Business Advisory Board
Apr 18, 2024 08:20AM Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Mar 14, 2024 08:45AM Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Mar 11, 2024 08:00AM Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Feb 12, 2024 07:30AM Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
Jan 29, 2024 08:50AM Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
Jan 23, 2024 07:56AM Anixa Biosciences (ANIX) Granted Japanese Patent on Ovarian Cancer Vaccine Technology
Jan 23, 2024 07:55AM Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Jan 10, 2024 09:00AM Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
Dec 14, 2023 07:15AM Anixa Biosciences to Present at Biotech Showcase 2024
Dec 6, 2023 06:00PM Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Dec 6, 2023 04:05PM Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Nov 27, 2023 08:30AM Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Oct 31, 2023 08:30AM Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
Oct 23, 2023 08:30AM Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
Oct 13, 2023 08:30AM Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial
Oct 3, 2023 08:32AM Anixa Biosciences (ANIX) Issued Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Oct 3, 2023 08:30AM Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Sep 19, 2023 08:30AM Anixa Biosciences Establishes Cancer Business Advisory Board
Aug 31, 2023 08:30AM Anixa Biosciences to Participate in September Investor Conferences
Aug 28, 2023 08:30AM Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial
Aug 14, 2023 08:30AM Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit
Aug 7, 2023 08:30AM Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial
Jul 27, 2023 08:31AM Anixa Biosciences (ANIX) Granted Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology
Jul 27, 2023 08:30AM Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology
Jul 11, 2023 08:34AM Anixa Biosciences (ANIX) Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology
Jul 11, 2023 08:30AM Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology
May 22, 2023 08:30AM Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial
Apr 17, 2023 03:27PM Anixa Biosciences Clarifies Poster Presentation on Company Website
Apr 17, 2023 01:35PM Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Mar 27, 2023 08:30AM Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting
Mar 13, 2023 08:31AM Anixa Biosciences (ANIX) Announces No Accounts at Silicon Valley Bank
Mar 13, 2023 08:30AM Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank
Mar 2, 2023 08:30AM Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Feb 27, 2023 08:31AM Anixa Biosciences (ANIX) Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology
Feb 27, 2023 08:30AM Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology
Feb 21, 2023 08:30AM Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board
Dec 19, 2022 08:30AM Anixa Biosciences to Present at Biotech Showcase 2023
Dec 8, 2022 08:30AM Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine
Nov 8, 2022 08:30AM Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
Oct 31, 2022 08:30AM Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy
Oct 26, 2022 08:30AM Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic
View More Recent Stories View Older Stories